Fragment Hits: What do They Look Like and How do They Bind?
暂无分享,去创建一个
Miklos Feher | Fabrizio Giordanetto | D. Shaw | F. Giordanetto | M. Feher | Chentian Jin | Lindsay Willmore | Chentian Jin | Lindsay Willmore | David E Shaw
[1] Kam Y. J. Zhang,et al. Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity , 2008, Proceedings of the National Academy of Sciences.
[2] Johannes Schiebel,et al. Six Biophysical Screening Methods Miss a Large Proportion of Crystallographically Discovered Fragment Hits: A Case Study. , 2016, ACS chemical biology.
[3] T. Blundell,et al. Fragment-based drug discovery in academia: Experiences from a tuberculosis programme , 2009 .
[4] G. G. Stokes. "J." , 1890, The New Yale Book of Quotations.
[5] G. McGaughey,et al. Discovery and Optimization of a Series of Pyrimidine-Based Phosphodiesterase 10A (PDE10A) Inhibitors through Fragment Screening, Structure-Based Design, and Parallel Synthesis. , 2015, Journal of medicinal chemistry.
[6] P. Hajduk,et al. Discovering High-Affinity Ligands for Proteins: SAR by NMR , 1996, Science.
[7] Tjelvar S. G. Olsson,et al. Identifying Interactions that Determine Fragment Binding at Protein Hotspots. , 2016, Journal of medicinal chemistry.
[8] G. Keserű,et al. On the enthalpic preference of fragment binding , 2016 .
[9] Christopher W Murray,et al. Opportunity Knocks: Organic Chemistry for Fragment-Based Drug Discovery (FBDD). , 2016, Angewandte Chemie.
[10] Gerhard Klebe,et al. A small nonrule of 3 compatible fragment library provides high hit rate of endothiapepsin crystal structures with various fragment chemotypes. , 2011, Journal of medicinal chemistry.
[11] Tjelvar S. G. Olsson,et al. The thermodynamics of protein-ligand interaction and solvation: insights for ligand design. , 2008, Journal of molecular biology.
[12] G. Klebe,et al. Experimental Active-Site Mapping by Fragments: Hot Spots Remote from the Catalytic Center of Endothiapepsin. , 2016, Journal of medicinal chemistry.
[13] M. Nishio,et al. The CH/π hydrogen bond in chemistry. Conformation, supramolecules, optical resolution and interactions involving carbohydrates. , 2011, Physical chemistry chemical physics : PCCP.
[14] W. Patrick Walters,et al. Prediction of Protein Pairs Sharing Common Active Ligands Using Protein Sequence, Structure, and Ligand Similarity , 2016, J. Chem. Inf. Model..
[15] B. Davis,et al. Targeting conserved water molecules: design of 4-aryl-5-cyanopyrrolo[2,3-d]pyrimidine Hsp90 inhibitors using fragment-based screening and structure-based optimization. , 2012, Bioorganic & medicinal chemistry.
[16] Paul N. Mortenson,et al. Fragment-to-Lead Medicinal Chemistry Publications in 2017. , 2018, Journal of medicinal chemistry.
[17] G. Keserű,et al. Fragment-based lead discovery on G-protein-coupled receptors , 2013, Expert opinion on drug discovery.
[18] Marcel L Verdonk,et al. Detection of secondary binding sites in proteins using fragment screening , 2015, Proceedings of the National Academy of Sciences.
[19] Edgar Jacoby,et al. Library design for fragment based screening. , 2005, Current topics in medicinal chemistry.
[20] R. Trievel,et al. Carbon-Oxygen Hydrogen Bonding in Biological Structure and Function , 2012, The Journal of Biological Chemistry.
[21] M. Congreve,et al. A 'rule of three' for fragment-based lead discovery? , 2003, Drug discovery today.
[22] Dima Kozakov,et al. Lessons from Hot Spot Analysis for Fragment-Based Drug Discovery. , 2015, Trends in pharmacological sciences.
[23] Tao Lu,et al. Intermolecular Sulfur···Oxygen Interactions: Theoretical and Statistical Investigations , 2015, J. Chem. Inf. Model..
[24] D. Scott,et al. Fragment-based approaches in drug discovery and chemical biology. , 2012, Biochemistry.
[25] Andrew R. Leach,et al. Molecular Complexity and Its Impact on the Probability of Finding Leads for Drug Discovery , 2001, J. Chem. Inf. Comput. Sci..
[26] C. Murray,et al. The rise of fragment-based drug discovery. , 2009, Nature chemistry.
[27] Rajarshi Guha,et al. KNIME Workflow to Assess PAINS Filters in SMARTS Format. Comparison of RDKit and Indigo Cheminformatics Libraries , 2011, Molecular informatics.
[28] David Rogers,et al. Extended-Connectivity Fingerprints , 2010, J. Chem. Inf. Model..
[29] P. Labute. proteins STRUCTURE O FUNCTION O BIOINFORMATICS Protonate3D: Assignment of ionization , 2013 .
[30] Christopher W Murray,et al. Experiences in fragment-based drug discovery. , 2012, Trends in pharmacological sciences.
[31] Gerhard Klebe,et al. Fragment Binding Can Be Either More Enthalpy-Driven or Entropy-Driven: Crystal Structures and Residual Hydration Patterns Suggest Why. , 2015, Journal of medicinal chemistry.
[32] J. Hert,et al. Interactive and Versatile Navigation of Structural Databases. , 2016, Journal of medicinal chemistry.
[33] Paul N. Mortenson,et al. Fragment-to-Lead Medicinal Chemistry Publications in 2018. , 2020, Journal of medicinal chemistry.
[34] Cathy H. Wu,et al. UniProt: the Universal Protein knowledgebase , 2004, Nucleic Acids Res..
[35] V. Nienaber,et al. Identification and optimization of PDE 10 A inhibitors using fragment-based screening by nanocalorimetry and X-ray crystallography , 2014 .
[36] Robert Kiss,et al. Virtual Fragment Docking by Glide: a Validation Study on 190 Protein-Fragment Complexes , 2010, J. Chem. Inf. Model..
[37] Daniel A Erlanson,et al. Introduction to fragment-based drug discovery. , 2012, Topics in current chemistry.
[38] G. Klebe. Applying thermodynamic profiling in lead finding and optimization , 2015, Nature Reviews Drug Discovery.
[39] L. Lam,et al. ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets , 2013, Nature Medicine.
[40] Harren Jhoti,et al. Twenty years on: the impact of fragments on drug discovery , 2016, Nature Reviews Drug Discovery.
[41] Paul N. Mortenson,et al. Fragment-to-Lead Medicinal Chemistry Publications in 2016. , 2017, Journal of medicinal chemistry.
[42] Pierangelo Metrangolo,et al. The Halogen Bond , 2016, Chemical reviews.
[43] Richard J. Hall,et al. Docking performance of fragments and druglike compounds. , 2011, Journal of medicinal chemistry.
[44] Gianni Chessari,et al. Fragment-based drug discovery applied to Hsp90. Discovery of two lead series with high ligand efficiency. , 2010, Journal of medicinal chemistry.
[45] W. Jencks,et al. On the attribution and additivity of binding energies. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[46] J Willem M Nissink,et al. Promiscuous 2-aminothiazoles (PrATs): a frequent hitting scaffold. , 2015, Journal of medicinal chemistry.
[47] T. N. Bhat,et al. The Protein Data Bank , 2000, Nucleic Acids Res..
[48] Vincent Le Guilloux,et al. Fpocket: An open source platform for ligand pocket detection , 2009, BMC Bioinformatics.
[49] Thomas A. Halgren. Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94 , 1996, J. Comput. Chem..
[50] Bernhard Rupp,et al. Models of protein–ligand crystal structures: trust, but verify , 2015, Journal of Computer-Aided Molecular Design.
[51] V. Nienaber,et al. Identification and Optimization of PDE10A Inhibitors Using Fragment-Based Screening by Nanocalorimetry and X-ray Crystallography , 2014, Journal of biomolecular screening.
[52] Iina Hellsten,et al. When fragments link: a bibliometric perspective on the development of fragment-based drug discovery. , 2018, Drug discovery today.
[53] O. Carugo,et al. How many water molecules can be detected by protein crystallography? , 1999, Acta crystallographica. Section D, Biological crystallography.
[54] Edward R Zartler,et al. Fragonomics: the -omics with real impact. , 2014, ACS medicinal chemistry letters.
[55] Martin Stahl,et al. Small Molecule Conformational Preferences Derived from Crystal Structure Data. A Medicinal Chemistry Focused Analysis , 2008, J. Chem. Inf. Model..
[56] A. Petrauskas,et al. ACD/Log P method description , 2000 .
[57] P. Hirth,et al. Vemurafenib: the first drug approved for BRAF-mutant cancer , 2012, Nature Reviews Drug Discovery.
[58] María Martín,et al. UniProt: A hub for protein information , 2015 .
[59] The Uniprot Consortium,et al. UniProt: a hub for protein information , 2014, Nucleic Acids Res..
[60] T. Blundell,et al. Structural biology in fragment-based drug design. , 2010, Current opinion in structural biology.
[61] György G. Ferenczy,et al. Thermodynamics of Fragment Binding , 2012, J. Chem. Inf. Model..
[62] J. Reymond. The chemical space project. , 2015, Accounts of chemical research.
[63] G. Bemis,et al. The properties of known drugs. 1. Molecular frameworks. , 1996, Journal of medicinal chemistry.
[64] C. Murray,et al. Fragment-to-Lead Medicinal Chemistry Publications in 2015. , 2017, Journal of medicinal chemistry.